MMP9 and heart failure: This cross-sectional study involved 188 Colombian participants classified for heart failure severity according to the New York Heart Association guidelines and showed a significant increase of circulating MMP-2 and MMP-9 activities in plasma from individuals who were seropositive for T. cruzi, as compared with seronegative controls.